Bertin Bioreagent
You are here :
- Bioreagent /
- Search Products /
- Products /
- Supplier /
- Cayman /
- GABAA Receptor ?1 Subunit Polyclonal Antibody
GABAA Receptor ?1 Subunit Polyclonal Antibody
-
Zoom
Cat No: 29266
GABAA receptors are ligand-gated chloride channels that mediate the effects of the inhibitory neurotransmitter GABA in the CNS.{46949,46950} They are postsynaptic heteropentameric receptors that contain protein subunits from the following isoforms: α1...
MoreThis product can only be bought through Cayman Chemical. Please contact us.
Territorial Availability: Available through Bertin Technologies only in France
Correlated keywords:
- GABA A ? 1 post synaptic ?6 ?4 ?3 ?3 ?2 ?2 GABRA 1 ECA4 EIEE19 EJM 5 EJM5
Product Overview:
GABAA receptors are ligand-gated chloride channels that mediate the effects of the inhibitory neurotransmitter GABA in the CNS.{46949,46950} They are postsynaptic heteropentameric receptors that contain protein subunits from the following isoforms: α1-6, β1-4, γ1-3, δ, ε, π, θ, and ρ1-3, arranged around a central pore. Phasic inhibitory synaptic transmission is regulated by α1β2γ2 subunit-containing GABAA receptors, the major isoform found in the brain.{46950,46951} The α subunit of GABAA receptors interfaces with a β subunit to form the GABA binding site that initiates GABA-induced action potentials and forms the benzodiazepine binding site with the γ subunit. Mutations in GABRA1, which encodes the α1 subunit isoform, are found in patients with autosomal dominant juvenile myoclonic epilepsy (JME), infantile spasms, and childhood absence epilepsy (CAE).{46950} GABRA1 expression is upregulated in ipsilateral, but not contralateral, perilesional tissue in a rat model of cortical ischemia-reperfusion injury.{55094} Cayman’s GABAA Receptor α1 Subunit Polyclonal Antibody can be used for immunohistochemistry (IHC) and Western blot (WB) applications. The antibody recognizes the GABAA receptor α1 subunit at approximately 51 kDa from mouse and rat samples.
GABAA receptors are ligand-gated chloride channels that mediate the effects of the inhibitory neurotransmitter GABA in the CNS.{46949,46950} They are postsynaptic heteropentameric receptors that contain protein subunits from the following isoforms: α1-6, β1-4, γ1-3, δ, ε, π, θ, and ρ1-3, arranged around a central pore. Phasic inhibitory synaptic transmission is regulated by α1β2γ2 subunit-containing GABAA receptors, the major isoform found in the brain.{46950,46951} The α subunit of GABAA receptors interfaces with a β subunit to form the GABA binding site that initiates GABA-induced action potentials and forms the benzodiazepine binding site with the γ subunit. Mutations in GABRA1, which encodes the α1 subunit isoform, are found in patients with autosomal dominant juvenile myoclonic epilepsy (JME), infantile spasms, and childhood absence epilepsy (CAE).{46950} GABRA1 expression is upregulated in ipsilateral, but not contralateral, perilesional tissue in a rat model of cortical ischemia-reperfusion injury.{55094} Cayman’s GABAA Receptor α1 Subunit Polyclonal Antibody can be used for immunohistochemistry (IHC) and Western blot (WB) applications. The antibody recognizes the GABAA receptor α1 subunit at approximately 51 kDa from mouse and rat samples.
| Size | 100 µl |
| Shipping | dry ice |
| Host | Rabbit |
| Antigen | Fusion protein from the cytoplasmic loop of the ?1 subunit of the rat GABAA receptor |
| Application(s) | IHC, WB |
| Formulation | 100 µl of affinity-purified polyclonal antibody |
| Custom Code | 3822.19 |
| UNSPSC code | 12352203 |
Click here to ask for your quote and get 15% off Cayman's products.
Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.
Follow Us
Contact us
Any project? Any challenge? We are in!
+33 (0)139 306 036
Any questions?
Contact us
Headquarters :
Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
View our other locations
Bertin Bioreagent
Copyright © Bertin Bioreagent - All rights reserved
Made by 
Loading...